What is BPC-157? BPC-157 is a synthetic peptide of 15 amino acids, called a pentadecapeptide, that is used in laboratory research. The name stands for Body Protection Compound-157. In published work, the BPC-157 peptide is studied in animal and cell models, mostly in connection with tissue repair, blood vessel growth and the gastrointestinal tract. Many people ask what BPC-157 does and what it is used for, so this overview answers those questions from a research point of view. It covers where the compound comes from, how it may work, what is known about safety and how it is regulated in the United States. For the chemical profile, see our BPC-157 research monograph.
BPC-157 Origin and Background
BPC-157 comes from research at the University of Zagreb in Croatia, where a group led by Predrag Sikirić studied protective proteins of the stomach. The compound is a partial sequence of a protein found in human gastric juice, which is what BPC-157 stands for: Body Protection Compound. The number 157 is the laboratory designation of the fragment. The 15-amino-acid fragment is reported to be stable in gastric juice, which is unusual for a peptide. Since the 1990s, most published work has come from the same group and a small number of other laboratories. Today the BPC-157 peptide is made by solid-phase synthesis, not extracted from tissue, and it is supplied only for laboratory research use.
Proposed Mechanisms of BPC-157 in Studies
How does BPC-157 work? The question is still open, because the evidence comes mainly from preclinical models. In those studies, BPC-157 has been linked to several pathways. They include the nitric oxide system, expression of vascular endothelial growth factor receptor 2 (VEGFR2) and signaling through the FAK-paxillin pathway, which is involved in cell migration. One study in rat tendon fibroblasts also reported higher growth hormone receptor expression after exposure. Together, these findings explain why researchers use the peptide in angiogenesis and cell migration models. Still, the exact molecular target of BPC-157 has not been identified, and no receptor has been confirmed. These mechanisms describe results in laboratory systems, not effects in humans.
BPC-157 Safety Data and Open Questions
Is BPC-157 safe? There is no established safety profile for humans. Animal studies from the originating group report few adverse findings, but independent replication is limited and long-term toxicity data are scarce. A 2025 systematic review in HSS Journal found that the evidence on BPC-157 is almost entirely preclinical and that more human research is needed. Whether BPC-157 works in people is therefore also unproven. Open questions include dose-response, the purity of research material, immune reactions and interactions. For these reasons the compound is sold for laboratory research use only, not for human or veterinary consumption.
BPC-157 Regulatory Status in the United States
Is BPC-157 FDA approved? No. It is not an approved drug in the United States and has no approved medical use. The FDA lists it among bulk drug substances that may present significant safety risks for compounding, citing limited safety data and the risk of immune reactions. So is BPC-157 legal? It can be sold as a research chemical for laboratory use, but not as a drug or for human use, and sellers who make health claims risk FDA action. The World Anti-Doping Agency also prohibits it as a non-approved substance. Researchers should check local rules before purchase.
BPC-157 Compared with Other Research Peptides
BPC-157 vs TB-500 is one of the most common comparisons in peptide research. TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in actin regulation and cell migration, while BPC-157 is derived from a gastric protein. The two differ in origin, length and the pathways studied, which is why laboratories sometimes test them side by side. Searches for BPC-157 and TB-500 together are common for the same reason. You can view TB-500 on its own page, or as a ready-made combination in the BPC-157 and TB-500 blend. Other peptides, such as GHK-Cu, are studied for different pathways again. The choice depends on the model and the question of the study.
Conclusion
BPC-157 is a 15-amino-acid synthetic peptide with a long preclinical research record and very limited human data. Studies point to several possible mechanisms, but the molecular target is unknown, safety in humans is not established and the compound is not FDA approved. That makes it a research tool, not a medicine. If you are planning laboratory work, start with a verified source and a Certificate of Analysis. You can review the BPC-157 research peptide with batch-level HPLC results. For laboratory research use only. Not for human or veterinary consumption.
Frequently Asked Questions
What is BPC-157 used for?
Only as a research compound in laboratory studies. It has no approved medical use.
Is BPC-157 safe?
No safety profile has been established for humans. It is sold for laboratory research use only.
Does BPC-157 work?
Findings come mainly from animal and cell studies. Evidence in humans is very limited, so effects in people are unproven.
Is BPC-157 FDA approved?
No. It is not an approved drug and has no approved medical use.